Apparatus, methods and composition for synthesis of cannabinoid compounds
The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
1. A biphasic composition comprising:
(a) a cannabinoid precursor in a first phase, wherein the cannabinoid precursor is compound of Formula II:
wherein R 1 is H or COOH and R 2 is a linear or branched CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 10 , C 6 H 13 , C 7 H 15 or C 8 H 17 group; and
(b) a cannabinoid synthase in a second phase,
wherein the first phase comprises an organic solvent and the second phase comprises an aqueous solvent, and wherein the organic solvent comprises olive oil, sesame oil, castor oil, cotton-seed oil, soybean oil, pentane, heptane, octane, isooctane, nonane, decane, or terpene.
2. The biphasic composition of claim 1 , wherein the organic solvent comprises a terpene.
3. The biphasic composition of claim 1 , wherein the terpene comprises dipentene.
4. The biphasic composition of claim 1 , wherein the organic solvent comprises olive oil, sesame oil, castor oil, cotton-seed oil, or soybean oil.
5. The biphasic composition of claim 1 , wherein the aqueous solvent further comprises dimethyl sulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMA), isopropyl alcohol, cyclodextrin, peroxide scavenger, or methanol (MeOH).
6. The biphasic composition of claim 1 , wherein the volume ratio of the first phase to the second phase is about 2:1.
7. The biphasic composition of claim 1 , wherein the aqueous solvent further comprises DMSO in a range between about 5% and about 10% of the aqueous solution, and wherein the pH value of the aqueous solution is between about 5.5 and about 7.5.
8. The biphasic composition of claim 1 , wherein the cannabinoid precursor is cannabigerolic acid (CBGA) or cannabigerovarinic acid (CBGVA).
9. The biphasic composition of claim 1 , wherein the cannabinoid synthase is CBDA synthase or THCA synthase.
10. A method for producing a cannabinoid product comprising:
contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the cannabinoid precursor is the compound of Formula II:
wherein R 1 is H or COOH and R 2 is a linear or branched CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 10 , C 6 H 13 , C 7 H 15 or C 8 H 17 group,
wherein the first phase comprises an organic solvent and the second phase comprises an aqueous solvent, and wherein the organic solvent comprises olive oil, sesame oil, castor oil, cotton-seed oil, soybean oil, pentane, heptane, octane, isooctane, nonane, decane, or terpene.
11. The method of claim 10 , wherein the organic solvent comprises a terpene.
12. The method of claim 11 , wherein the terpene comprises dipentene.
13. The method of claim 10 , wherein the organic solvent comprises olive oil, sesame oil, castor oil, cotton-seed oil, or soybean oil.
14. The method of claim 10 , wherein the aqueous solvent further comprises dimethyl sulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMA), isopropyl alcohol, cyclodextrin, peroxide scavenger, or methanol (MeOH).
15. The method of claim 10 , wherein the volume ratio of the first phase to the second phase is about 2:1.
16. The method of claim 10 , wherein the aqueous solvent further comprises DMSO in a range between about 5% and about 10% of the aqueous solution, and wherein the pH value of the aqueous solution is between about 5.5 and about 7.5.
17. The method of claim 10 , wherein the cannabinoid precursor is cannabigerolic acid (CBGA) or cannabigerovarinic acid (CBGVA).
18. The method of claim 10 , wherein the cannabinoid synthase is CBDA synthase or THCA synthase.
19. The method of claim 10 further comprising agitating the first phase to form micro-droplets comprising the cannabinoid precursor.